Ligand profile
ZINC3188764
Virtual-screening candidate from ZINC.
Bound to: KP13_02775 — Cystathionine beta-lyase metC
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3188764- UniProt (similar protein)
P06721- Tanimoto
- 0.676
- Target protein
- KP13_02775
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 29.1
- −1 ≤ LogP ≤ 5 4.38
- MW ≤ 500 Da 339.2
- LogP ≤ 5 4.38
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 1
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 29.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(Nc1ccccc1C(F)(F)F)C(C(F)(F)F)C(F)(F)FO=C(Nc1ccccc1C(F)(F)F)C(C(F)(F)F)C(F)(F)F
InChI=1S/C11H6F9NO/c12-9(13,14)5-3-1-2-4-6(5)21-8(22)7(10(15,16)17)11(18,19)20/h1-4,7H,(H,21,22)InChI=1S/C11H6F9NO/c12-9(13,14)5-3-1-2-4-6(5)21-8(22)7(10(15,16)17)11(18,19)20/h1-4,7H,(H,21,22)
PDMRRHFTUZDGEC-UHFFFAOYSA-NPDMRRHFTUZDGEC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL218090
- Homolog
- P06721
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3188764 →
- ZINC ZINC20 ZINC3188764 →
- UniProt UniProt P06721 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3188764”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02775.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).